CELLBIXAN
Laboratoire Français; du Fractionnementet des Biotechnologies
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79062084 |
| Registration Number | 3643871 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | H |
| Law Office Assigned | M40 |
| Employee Name | KEAN, AMY C |
Timeline
| 2008-09-26 | Application Filed |
| 2009-04-07 | Published for Opposition |
| 2009-06-23 | Location: PUBLICATION AND ISSUE SECTION |
| 2009-06-23 | Trademark Registered |
| 2018-09-26 | Cancelled |
| 2018-09-26 | Status: Dead/Cancelled |
| 2019-04-27 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Laboratoire Français; du Fractionnementet des Biotechnologies |
| Entity Statement | SOCIETE ANONYME |
| Address | 3 avenue des Tropiques F-91940 Les Ulis FR |
| Legal Entity Type | |
| Legal Entity State | FR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Recombinant monoclonal antibody directed against CD 20, for disease testing and medical treatment use |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2008-12-12 | 1 REPR M: |
| NEW APPLICATION ENTERED IN TRAM | 2008-12-15 | 2 NWAP I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2008-12-19 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2008-12-27 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2008-12-29 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2008-12-30 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2008-12-31 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2008-12-31 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2009-01-30 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2009-02-23 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2009-02-23 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2009-02-23 | 12 TEME I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-02-23 | 13 TCCA I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2009-02-24 | 14 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2009-02-27 | 15 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2009-02-27 | 16 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2009-03-18 | 17 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2009-04-07 | 18 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2009-06-23 | 19 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2009-09-24 | 20 FICR P: |
| FINAL DISPOSITION PROCESSED | 2009-10-06 | 21 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2009-10-06 | 22 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2013-03-31 | 23 FINO P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2014-07-21 | 24 NREP P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2015-03-26 | 25 NREP P: |
| CANCELLED SECTION 71 | 2016-01-29 | 26 C71T O:Outgoing Correspondence |
| TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | 2016-09-29 | 27 INTR P: |
| GENERIC MADRID TRANSACTION CREATED | 2016-09-30 | 28 XXCR P: |
| GENERIC MADRID TRANSACTION SENT TO IB | 2016-09-30 | 29 XXSS O:Outgoing Correspondence |
| TOTAL INVALIDATION PROCESSED BY THE IB | 2017-03-24 | 30 INNT P: |
| DEATH OF INTERNATIONAL REGISTRATION | 2019-04-26 | 31 DETH P: |
| NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | 2019-04-26 | 32 DENC O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 CELLBIXAN 79379913 not registered Live/Pending |
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES 2023-07-19 |
 CELLBIXAN 79062084 3643871 Dead/Cancelled |
Laboratoire Français; du Fractionnementet des Biotechnologies 2008-09-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 